Literature DB >> 14534400

Update on pathogenesis of cystic fibrosis lung disease.

Scott H Donaldson1, Richard C Boucher.   

Abstract

PURPOSE OF REVIEW: It has been an ongoing challenge to translate knowledge pertaining to the molecular basis of cystic fibrosis (CF) into a clear understanding of the development of CF lung disease. Various hypotheses have attempted to explain the apparent breach of innate defenses in CF, although a definitive explanation has been elusive. RECENT
FINDINGS: Recent data suggest that altered ion transport functions--namely sodium hyperabsorption and reduced chloride secretion--lead to a depletion of airway surface liquid. As a result, the overlying mucus layer may encroach upon cell surfaces and become adherent, thus interfering with cilia-dependent and cough clearance. These static, and ultimately anaerobic, niches provide a favorable environment for the development of bacterial biofilms and persistent infection with Pseudomonas aeruginosa.
SUMMARY: With a better understanding of pathogenic steps leading to CF lung disease, we may now be able to direct the development of therapies that will substantially improve disease outcomes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14534400     DOI: 10.1097/00063198-200311000-00007

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  32 in total

1.  Lymphocytes in cystic fibrosis lung disease: a tale of two immunities.

Authors:  R B Moss
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

Review 2.  Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.

Authors:  Thomas Bjarnsholt; Michael Givskov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-07-29       Impact factor: 6.237

3.  Birth of mucus.

Authors:  Paul M Quinton
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-10-23       Impact factor: 5.464

Review 4.  Ion channels in asthma.

Authors:  Miguel A Valverde; Gerard Cantero-Recasens; Anna Garcia-Elias; Carole Jung; Amado Carreras-Sureda; Rubén Vicente
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

5.  Population Dynamics of Staphylococcus aureus in Cystic Fibrosis Patients To Determine Transmission Events by Use of Whole-Genome Sequencing.

Authors:  Andrea Ankrum; Barry G Hall
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

6.  Vitamin B12-mediated restoration of defective anaerobic growth leads to reduced biofilm formation in Pseudomonas aeruginosa.

Authors:  Kang-Mu Lee; Junhyeok Go; Mi Young Yoon; Yongjin Park; Sang Cheol Kim; Dong Eun Yong; Sang Sun Yoon
Journal:  Infect Immun       Date:  2012-02-27       Impact factor: 3.441

Review 7.  Duration of intravenous antibiotic therapy in people with cystic fibrosis.

Authors:  Amanda Plummer; Martin Wildman; Tim Gleeson
Journal:  Cochrane Database Syst Rev       Date:  2016-09-01

8.  CFTR fails to inhibit the epithelial sodium channel ENaC expressed in Xenopus laevis oocytes.

Authors:  G Nagel; P Barbry; H Chabot; E Brochiero; K Hartung; R Grygorczyk
Journal:  J Physiol       Date:  2005-03-03       Impact factor: 5.182

Review 9.  What's new in cystic fibrosis? From treating symptoms to correction of the basic defect.

Authors:  Marijke Proesmans; François Vermeulen; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2008-04-04       Impact factor: 3.183

10.  Effects of Emulsion Composition on Pulmonary Tobramycin Delivery During Antibacterial Perfluorocarbon Ventilation.

Authors:  Ryan A Orizondo; Mario L Fabiilli; Marissa A Morales; Keith E Cook
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-01-07       Impact factor: 2.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.